Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2, 3,6- tetrahydropyridine-induced Parkinson's disease model

Neurological Research

Volumn 32, Issue SUPPL.1, 2010, Pages

  Hong, Mee Sook ^a   Park, Hun Kuk ^a   Yang, Jong Soo ^a   Park, Hi Joon ^a   Kim, Seung Tae ^b   Kim, Seung Nam ^a   Park, Ji Yeun ^a   Song, Jeong Yoon ^c   Park, Hyun Kyung ^c   Jo, Dae Jean ^c   Park, Sung Wook ^c   HwanYun, Dong ^c   Ban, Ju Yeon ^d   Chung, Joo Ho ^a  

^a Kyung Hee University   (South Korea)

^b Pusan National University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d Institute of Tissue Regeneration Engineering   (South Korea)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Acupuncture; Biomarker; Microarray; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; COMPLEMENTARY DNA; MESSENGER RNA;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA HYBRIDIZATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ACUPUNCTURE THERAPY; ANIMALS; BIOLOGICAL MARKERS; DATABASES, GENETIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; INTERNET; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSONIAN DISORDERS; RANDOM ALLOCATION; RNA, MESSENGER; SOFTWARE; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 77949452045     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109X     Document Type: Article

References (23)

1. von Campenhausen S, Bornschein B,Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473-490
2. Vanitallie TB. Parkinson disease: Primacy of age as a risk factor for mitochondrial dysfunction. Metabolism 2008; 57 (Suppl. 2): S50-S55
3. Payami H, Zareparsi S. Genetic epidemiology of Parkinson's disease. J Geriatr Psychiatry Neurol 1998; 11: 98-106
4. Fukuda T. Neurotoxicity of MPTP. Neuropathology 2001; 21: 323-332
5. Wichmann T, DeLong MR. Pathophysiology of Parkinson's disease: The MPTP primate model of the human disorder. Ann NY Acad Sci 2003; 991: 199-213
6. Grünblatt E, Mandel S, Youdim M, et al. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J Neurochem 2001; 78: 1-12
7. Youdim MB, Grünblatt E, Mandel S, et al. Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron. Neurotox Res 2002; 4: 679-689
8. Lee H, Park HJ, Park J, et al. Acupuncture application for neurological disorders. Neurol Res 2007; 29 (Suppl. 1): S49-S54
9. Liang XB, Liu XY, Li FQ, et al. Long-term high frequency electroacupuncture stimulation prevents neuronal degeneration and upregulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Mol Brain Res 2002; 108: 51-59
10. Guo JC, Gao HM, Chen J, et al. Modulation of the gene expression in the protective effects of electroacupuncture against cerebral ischemia: A cDNA microarray study. Acupunct Electrother Res 2004; 29: 173-186
11. Shiue HS, Lee YS, Tsai CN, et al. DNA microarray analysis of the effect on inflammation in patients treated with acupuncture for allergic rhinitis. J Altern Complement Med 2008; 14: 689-698
12. Ko J, Na DS, Lee YH, et al. cDNA microarray analysis of the differential gene expression in the neuropathic pain and electroacupuncture treatment models. J Biochem Mol Biol 2002; 35: 420-427
13. Jeon S, Kim YJ, Kim ST, et al. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics 2008; 8: 4822-4832
14. WHO Regional Office for the Western Pacific. WHO Standard Acupuncture Point Locations in the Western Pacific Region, Bernan: WHO Regional Office for the Western Pacific, 2008
15. Hayley S, Crocker SJ, Shree T, et al. Regulation of dopaminergic loss by Fas in a 1-ethyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2004; 24: 2045-2053
16. Yin CS, Jeong HS, Park HJ, et al. A proposed transpositional acupoint system in a mouse and rat model. Res Vet Sci 2008; 84: 159-165
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57
18. Ren XM. Fifty cases of Parkinson's disease treated by acupuncture combined with madopar. J Tradit Chin Med 2008; 28: 255-257
19. Wang X, Liang XB, Li FQ, et al. Therapeutic strategies for Parkinson's disease: The ancient meets the future-traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res 2008; 33: 1956-1963
20. Koutsilieri E, Riederer P. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease. Parkinsonism Relat Disord 2007; 13 (Suppl. 3): S329-S331
21. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol 2009; 8: 382-397
22. Fuxe KG, Tarakanov AO, Goncharova LB, et al. A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 2008; 58: 453-458
23. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance. Ann NY Acad Sci 2008; 1147: 93-104